Arcus Biosciences Inc RCUS:NYSE

Last Price$27.20NYSE Previous Close - Last Trade as of 7:00PM ET 8/12/22

Today's Change0(0.00%)
Bid (Size)$25.05 (2)
Ask (Size)$45.00 (1)
Day Low / HighN/A - N/A
Volume982.5 K
 

View Biotechnology IndustryPeer Comparison as of 08/12/2022

 

Arcus Biosciences Inc ( NYSE )

Price: $27.20
Change: +1.32 (5.10%)
Volume: 982.5 K
7:00PM ET 8/12/2022
 
 

Pacific Biosciences of California Inc ( NASDAQ )

Price: $8.79
Change: +0.85 (10.71%)
Volume: 22.3 M
4:00PM ET 8/12/2022
 
 

Iovance Biotherapeutics Inc ( NASDAQ )

Price: $12.66
Change: +0.82 (6.93%)
Volume: 1.8 M
4:00PM ET 8/12/2022
 
 

Krystal Biotech Inc ( NASDAQ )

Price: $79.30
Change: +5.87 (7.99%)
Volume: 281.7 K
4:00PM ET 8/12/2022
 
 

Axsome Therapeutics Inc ( NASDAQ )

Price: $46.27
Change: +0.95 (2.10%)
Volume: 603.2 K
4:00PM ET 8/12/2022
 

Read more news Recent News

--Goldman Sachs Adjusts Arcus Biosciences' Price Target to $29 From $28, Maintains Neutral Rating
11:19AM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--SVB Securities Adjusts Arcus Biosciences' Price Target to $49 from $66, Keeps Outperform Rating
11:13AM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Wedbush Adjusts Price Target on Arcus Biosciences to $36 From $42, Keeps Outperform Rating
6:03AM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q2 Revenue $26.8M
4:13PM ET 8/03/2022 MT Newswires

...

Company Profile

Business DescriptionArcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA. View company web site for more details
Address3928 Point Eden Way
Hayward, California 94545
Phone+1.510.694.6200
Number of Employees108
Recent SEC Filing08/08/20223
Chairman & Chief Executive OfficerTerry J. Rosen
President & DirectorJuan Carlos Jaen
Chief Operating Officer & DirectorJennifer A. Jarrett
Chief Financial & Accounting OfficerRobert C. Goeltz

Company Highlights

Price Open$26.27
Previous Close$25.88
52 Week Range$16.74 - 49.10
Market Capitalization$2.0 B
Shares Outstanding72.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/14/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings38.31
Earnings per Share$0.71
Beta vs. S&P 500N/A
Revenue$8.4 M
Net Profit Margin16.34%
Return on Equity9.12%

Analyst Ratings as of 08/04/2022

Buy
9
Overweight
1
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset